117 related articles for article (PubMed ID: 37591367)
21. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
22. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancer.
Frik M; Martínez A; Elie BT; Gonzalo O; Ramírez de Mingo D; Sanaú M; Sánchez-Delgado R; Sadhukha T; Prabha S; Ramos JW; Marzo I; Contel M
J Med Chem; 2014 Dec; 57(23):9995-10012. PubMed ID: 25409416
[TBL] [Abstract][Full Text] [Related]
24. Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems.
Ferraro MG; Piccolo M; Misso G; Maione F; Montesarchio D; Caraglia M; Paduano L; Santamaria R; Irace C
Cells; 2020 Jun; 9(6):. PubMed ID: 32517101
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo anti-cancer effects of hibernating common carp (Cyprinus carpio) plasma on metastatic triple-negative breast cancer.
Golpich M; Amini E; Kefayat A; Fesharaki M; Moshtaghian J
Sci Rep; 2022 Feb; 12(1):2855. PubMed ID: 35190572
[TBL] [Abstract][Full Text] [Related]
26. Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo.
Mohamed Subarkhan MK; Ren L; Xie B; Chen C; Wang Y; Wang H
Eur J Med Chem; 2019 Oct; 179():246-256. PubMed ID: 31255925
[TBL] [Abstract][Full Text] [Related]
27. Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]
Purushothaman B; Arumugam P; Ju H; Kulsi G; Samson AAS; Song JM
Eur J Med Chem; 2018 Aug; 156():747-759. PubMed ID: 30048924
[TBL] [Abstract][Full Text] [Related]
28. BRCA1-Associated Triple-Negative Breast Cancer and Potential Treatment for Ruthenium-Based Compounds.
Hongthong K; Ratanaphan A
Curr Cancer Drug Targets; 2016; 16(7):606-17. PubMed ID: 26845433
[TBL] [Abstract][Full Text] [Related]
29. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
30. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
[TBL] [Abstract][Full Text] [Related]
31. Fine-tuning the cytotoxicity of ruthenium(II) arene compounds to enhance selectivity against breast cancers.
Pereira SAP; Romano-deGea J; Barbosa AI; Costa Lima SA; Dyson PJ; Saraiva MLMFS
Dalton Trans; 2023 Aug; 52(33):11679-11690. PubMed ID: 37552495
[TBL] [Abstract][Full Text] [Related]
32. Organometallic dendrimers based on Ruthenium(II) N-heterocyclic carbenes and their implication as delivery systems of anticancer small interfering RNA.
Rodríguez-Prieto T; Michlewska S; Hołota M; Ionov M; de la Mata FJ; Cano J; Bryszewska M; Gómez R
J Inorg Biochem; 2021 Oct; 223():111540. PubMed ID: 34273717
[TBL] [Abstract][Full Text] [Related]
33. Ruthenium dendrimers against acute promyelocytic leukemia:
Michlewska S; Ionov M; Maroto-Díaz M; Szwed A; Ihnatsyeu-Kachan A; Abashkin V; Dzmitruk V; Rogalska A; Denel M; Gapinska M; Shcharbin D; Gomez Ramirez R; de la Mata FJ; Bryszewska M
Future Med Chem; 2019 Jul; 11(14):1741-1756. PubMed ID: 31287722
[TBL] [Abstract][Full Text] [Related]
34. Rationally Designed Ruthenium Complexes for Breast Cancer Therapy.
Golbaghi G; Castonguay A
Molecules; 2020 Jan; 25(2):. PubMed ID: 31936496
[TBL] [Abstract][Full Text] [Related]
35. A Half-Sandwich Ruthenium(II) (N^N) Complex: Inducing Immunogenic Melanoma Cell Death in Vitro and in Vivo.
Xu Z; Xu M; Wu X; Guo S; Tian Z; Zhu D; Yang J; Fu J; Li X; Song G; Liu Z; Song X
ChemMedChem; 2023 Aug; 18(16):e202300131. PubMed ID: 37226330
[TBL] [Abstract][Full Text] [Related]
36. Polymeric micelle-mediated delivery of half-sandwich ruthenium(II) complexes with phosphanes derived from fluoroloquinolones for lung adenocarcinoma treatment.
Kołoczek P; Skórska-Stania A; Cierniak A; Sebastian V; Komarnicka UK; Płotek M; Kyzioł A
Eur J Pharm Biopharm; 2018 Jul; 128():69-81. PubMed ID: 29678734
[TBL] [Abstract][Full Text] [Related]
37. Picolinate ruthenium(II)-arene complex with in vitro antiproliferative and antimetastatic properties: comparison to a series of ruthenium(II)-arene complexes with similar structure.
Gligorijević N; Aranđelović S; Filipović L; Jakovljević K; Janković R; Grgurić-Šipka S; Ivanović I; Radulović S; Tešić ZLj
J Inorg Biochem; 2012 Mar; 108():53-61. PubMed ID: 22266461
[TBL] [Abstract][Full Text] [Related]
38.
Gopalakrishnan D; Saravanan S; Merckx R; Madan Kumar A; Khamrang T; Velusamy M; Vasanth K; Sunitha S; Hoogenboom R; Maji S; Ganeshpandian M
Dalton Trans; 2021 Jun; 50(23):8232-8242. PubMed ID: 34037018
[TBL] [Abstract][Full Text] [Related]
39. Differential Cytotoxicity, Cellular Uptake, Apoptosis and Inhibition of BRCA1 Expression of BRCA1-Defective and Sporadic Breast Cancer Cells Induced by an Anticancer Ruthenium(II)-Arene Compound, RAPTA-EA1.
Ratanaphan A; Nhukeaw T; Hongthong K; Dyson PJ
Anticancer Agents Med Chem; 2017; 17(2):212-220. PubMed ID: 27039925
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes.
Kavukcu SB; Şahin O; Seda Vatansever H; Kurt FO; Korkmaz M; Kendirci R; Pelit L; Türkmen H
Bioorg Chem; 2020 Jun; 99():103793. PubMed ID: 32278205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]